<DOC>
<DOCNO>EP-0621276</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Angiotensin II receptor blocking 2,3,6-substituted quinazolinones.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K31505	A61K31505	A61K31517	A61K31517	A61K31535	A61K31535	A61K3155	A61K3155	A61P900	A61P900	A61P912	A61P4300	A61P4300	C07D23900	C07D23990	C07D23991	C07D40300	C07D40310	C07D49800	C07D49804	C07F700	C07F708	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	A61P	A61P	A61P	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07F	C07F	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61P9	A61P9	A61P9	A61P43	A61P43	C07D239	C07D239	C07D239	C07D403	C07D403	C07D498	C07D498	C07F7	C07F7	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
This disclosure describes novel 2, 3,6, substituted 
quinazolinones of the formula: 


wherein R₁, R⁶ and X are described in the specification 
which have activity as angiotensin II (AII) 

antagonistis. 
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
AMERICAN CYANAMID CO
</APPLICANT-NAME>
<APPLICANT-NAME>
AMERICAN CYANAMID COMPANY
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
LEVIN JEREMY I
</INVENTOR-NAME>
<INVENTOR-NAME>
VENKATESAN ARANAPAKAM M
</INVENTOR-NAME>
<INVENTOR-NAME>
LEVIN, JEREMY I.
</INVENTOR-NAME>
<INVENTOR-NAME>
VENKATESAN, ARANAPAKAM M.
</INVENTOR-NAME>
</INVENTORS>
<DESCRIPTION>
This invention relates to certain 6-(polycyclic 
heterocyclic)-2-(lower alkyl)-3-(substituted) 
quinazolinone compounds which have demonstrated activity 
as angiotensin II (AII) antagonists and are therefore 
useful in alleviating angiotensin induced hypertension 
and for treating congestive heart failure. According to the present invention, there are 
provided novel 6-(polycyclic heterocyclic)-2-(lower 
alkyl)-3-(substituted) quinazolinone compounds of Formula 
I which have angiotensin II antagonizing properties 
and are useful as anti-hypertensives: 
wherein:
 
R is 
-CO₂H or -NHSO₂CF₃;
 
X is lower alkyl of 3 to 5 carbon atoms;
 
R⁶ is: 
R¹ is H, lower alkyl of 1 to 4 carbon atoms (optionally 
substituted with -OR⁷, -CO₂R⁷, -CN, -N(R⁷)(R¹³), 
phenyl, substituted phenyl (substitution selected from 
mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 
nitro, O-alkyl of 1 to 3 carbon atoms, F, Cl, 
or Br)), phenyl, substituted phenyl (substitution selected 
from mono-lower alkyl of 1 to 3 carbon atoms, 
trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 
F, Cl, or Br), pyridine, thiophene, furan, -OR⁷, 
-CO₂R⁷, -CN, -CON(R⁷)(R¹³), -CF₃, -SPh, -N(R⁷)(R¹³) or  R² is H, lower alkyl of 1 to 4 carbon atoms (optionally 
substituted with -OR⁷,-CO₂R⁷, -CN, -N(R⁷)(R¹³), 
phenyl, substituted phenyl (substitution selected from 
mono-lower alkyl of 1 to 3 carbon atoms, 
trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 
F, Cl, or Br)), phenyl, substituted phenyl (substitution 
selected from mono-lower alkyl of 1 to 3 carbon 
atoms, trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon 
atoms, F, Cl, or Br), pyridine, thiophene, furan, -CO₂R⁷, 
-CN, -CON(R⁷)(R¹³), or 
R³ is H, lower alkyl of 1 to 4 carbon atoms, phenyl, 
substituted phenyl (substitution selected from 
mono-lower alkyl of 1 to 3 carbon atoms, 
trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 
F, Cl, or Br), pyridine, thiophene or furan, -CO₂R⁷, 
-CON(R⁷)(R¹³), -CN, -NO₂, or 
R⁴ is H, -CO₂R⁷, -SO₂R¹², lower alkyl of 1 to 4 carbon 
atoms, benzyl, substituted benzyl (substitution selected 
from mono-lower alkyl of 1 to 3 carbon atoms, 
trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 
F, Cl, or Br), phenyl, substituted phenyl (substitution  
 
selected from mono-lower alkyl of 1 to 3 carbon atoms, 
trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 
F, Cl, or Br), -CON(R⁷)(R¹³), or 
R¹² is phenyl, substituted phenyl (substitution selected 
from mono-lower alkyl of 1 to 3 carbon atoms, 
trifluoromethyl, nitro, O-alkyl of 1
</DESCRIPTION>
<CLAIMS>
A quinazolinone compound having the formula: 
 

wherein: 
R is 

 
-CO₂H or -NHSO₂CF₃; 

X is lower alkyl of 3 to 5 carbon atoms; 
R⁶ is:

 
or Br)), phenyl, substituted phenyl (substitution selected 

from mono-lower alkyl of 1 to 3 carbon atoms, 
trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 

F, Cl, or Br), pyridine, thiophene, furan, -CO₂R⁷, -CN, 
-CON(R⁷)(R¹³), or 

 
R³ is H, lower alkyl of 1 to 4 carbon atoms, phenyl, 

substituted phenyl (substitution selected from 
mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 

nitro, O-alkyl of 1 to 3 carbon atoms, F, Cl, 
or Br), pyridine, thiophene or furan, -CO₂R⁷, 

-CON(R⁷)(R¹³), -CN, -NO₂, or 
 

R⁴ is H, -CO₂R⁷, -SO₂R¹², lower alkyl of 1 to 4 carbon 
atoms, benzyl, substituted benzyl (substitution selected 

from mono-lower alkyl of 1 to 3 carbon atoms, 
trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 

F, Cl, or Br) phenyl, substituted phenyl (substitution 
selected from mono-lower alkyl of 1 to 3 carbon atoms, 

trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 
F, Cl, or Br), -CON(R⁷)(R¹³), or  

R¹² is phenyl, substituted phenyl (substitution selected 
from mono-lower alkyl of 1 to 3 carbon atoms, 

trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 
F, Cl, or Br); 

R⁵ is H, lower alkyl of 1 to 4 carbon atoms; 
R⁷ is H, lower alkyl of 1 to 4 carbon atoms; 

R⁸ is H, lower alkyl of 1 to 4 carbon atoms, phenyl, 
substituted phenyl (substitution selected from 

mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 
nitro, O-alkyl of 1 to 3 carbon atoms, F, Cl, 

or Br), -CO₂R⁷, -CH₂OH, -CN, -CON(R⁷)(R¹³), or 
 

R⁹ is H, lower alkyl of 1 to 4 carbon atoms, phenyl, 
substituted phenyl (substitution selected from 

mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 
nitro, O-alkyl of 1 to 3 carbon atoms, F, Cl, 

or Br); 
R¹⁰ is H, lower alkyl of 1 to 4 carbon atoms (optionally 

substituted with -OR⁷, -CO₂R⁷, -CN, -N(R⁷)(R¹³), 
phenyl, substituted phenyl (substitution selected from 

mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 
nitro, O-alkyl of 1 to 3 carbon atoms, F, Cl, 

or Br)), phenyl, substituted phenyl (substitution selected 
from mono-lower alkyl of 1 to 3 carbon atoms, 

trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 
F, Cl, or Br), pyridine, thiophene, furan, -OR⁷, 

-CO₂R⁷, -CN, -CON(R⁷)(R¹³), -CF₃, or  
R¹³ is H, lower alkyl of 1 to 4 carbon atoms; 

Q is -O-, -(CR¹¹R¹⁴)n or a single bond; 
Q¹ is -O-, -(CR¹¹R¹⁴)n-, 

 
or a single bond ; 

n is 1 to 5; 
A is -(CR¹¹R¹⁴)m-; 

m is 2 to 5, provided that n + m is not greater than 6; 

R¹¹ is H, lower alkyl of 1 to 4 carbon atoms (optionally 
substituted with -OR⁷, -CO₂R⁷, -CN, -N(R⁷) (R¹³), 

phenyl, substituted phenyl (substitution selected from 
mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 

nitro, O-alkyl of 1 to 3 carbon atoms, F, Cl, 
or Br)), phenyl, substituted phenyl (substitution selected 

from mono-lower alkyl of 1 to 3 carbon atoms, 
trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 

F, C1, or Br), pyridine, thiophene, furan, -OR⁷, 
-CO₂R⁷, -CN, -CON(R⁷)(R¹³), -CF₃, or 

 
R¹⁴ is H, lower alkyl of 1 to 4 carbon atoms (optionally 

substituted with -OR⁷, -CO₂R⁷, -CN, -N(R⁷)(R¹³), 
phenyl, substituted phenyl (substitution selected from 

mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 
nitro, O-alkyl of 1 to 3 carbon atoms, F, C1, 

 
or Br)), phenyl, substituted phenyl (substitution selected 

from mono-lower alkyl of 1 to 3 carbon atoms, 
trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 

F, C1, or Br), pyridine, thiophene, furan, -OR⁷, 
-CO₂R⁷, -CN, -CON(R⁷)(R¹³), -CF₃, or 

 
and pharmaceutically acceptable salts thereof. 
The compound according to Claim 1 wherein 
said salts are selected from potassium, sodium, calcium, 

magnesium or ammonium. 
The compound according to claim 1 wherein 
   R is 

 
X is straight chain alkyl of 4 carbon atoms; 

   R⁶ is : 
 

Q is a single bond and m is 2 or 3. 
The compound according to Claim 1 wherein 
X is a straight chain alkyl of 3 or 4 carbon atoms; 

R⁶ is 
A quinazolinone compound having the formula: 
 

wherein: 
R is 

 
X is lower alkyl of 3 to 5 carbon atoms; 

R⁶ is:  
R¹ is H, lower alkyl of 1 to 4 carbon atoms (optionally 

substituted with -OR⁷, -CO₂R⁷, -CN, -N(R⁷)(R¹³), 
phenyl, substituted phenyl (substitution selected from 

mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 
nitro, O-alkyl of 1 to 3 carbon atoms, F, Cl, 

or Br)), phenyl, substituted phenyl (substitution 
selected from mono-lower alkyl of 1 to 3 carbon atoms, 

trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 
F, Cl, or Br), pyridine, thiophene, furan, -OR⁷, 

-CO₂R⁷, -CN, -CON(R⁷)(R¹³), -CF₃, -SPh, -N(R⁷)(R¹³) or 
 

R² is H, lower alkyl of 1 to 4 carbon atoms (optionally 
substituted with -OR⁷, -CO₂R⁷, -CN, -N(R⁷)(R¹³), 

phenyl, substituted phenyl (substitution selected from 
mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 

nitro, O-alkyl of 1 to 3 carbon atoms, F, Cl, 
or Br)), phenyl, substituted phenyl (substitution selected 

from mono-lower alkyl of 1 to 3 carbon atoms, 
trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 

 
F, Cl, or Br), pyridine, thiophene, furan, -CO₂R⁷, -CN, 

-CON(R⁷) (R¹³), or 
 

R³ is H, lower alkyl of 1 to 4 carbon atoms, phenyl, 
substituted phenyl (substitution selected from 

mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 
nitro, O-alkyl of 1 to 3 carbon atoms, F, Cl, 

or Br), pyridine, thiophene or furan, -CO₂R⁷, 
-CON(R⁷)(R¹³), -CN, -NO₂, or 

 
R⁴ is H, -CO₂R⁷, -SO₂R¹², lower alkyl of 1 to 4 carbon 

atoms, benzyl, substituted benzyl (substitution selected 
from mono-lower alkyl of 1 to 3 carbon atoms, 

trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 
F, Cl, or Br) phenyl, substituted phenyl (substitution 

selected from mono-lower alkyl of 1 to 3 carbon atoms, 
trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 

F, Cl, or Br), -CON(R⁷)(R¹³), or 
 

R¹² is phenyl, substituted phenyl (substitution selected 
from mono-lower alkyl of 1 to 3 carbon atoms, 

 
trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 

F, Cl, or Br); 
R⁵ is H, lower alkyl of 1 to 4 carbon atoms; 

R⁷ is H, lower alkyl of 1 to 4 carbon atoms; 
R⁸ is H, lower alkyl of 1 to 4 carbon atoms, phenyl, 

substituted phenyl (substitution selected from 
mono-lower alkyl of 1 to 3 carbon atoms, 

trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 
F, Cl, or Br), -CO₂R⁷, -CH₂OH, -CN, -CON(R⁷)(R¹³), or 

 
R⁹ is H, lower alkyl of 1 to 4 carbon atoms, phenyl, 

substituted phenyl (substitution selected from 
mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 

nitro, O-alkyl of 1 to 3 carbon atoms, F, Cl, 
or Br); 

R¹⁰ is H, lower alkyl of 1 to 4 carbon atoms (optionally 
substituted with -OR⁷, -CO₂R⁷, -CN, -N(R⁷)(R¹³), 

phenyl, substituted phenyl (substitution selected from 
mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 

nitro, O-alkyl of 1 to 3 carbon atoms, F, 
Cl, or Br)), phenyl, substituted phenyl (substitution 

selected from mono-lower alkyl of 1 to 3 carbon atoms, 
trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 

F, Cl, or Br), pyridine, thiophene, furan, -OR⁷, 
-CO₂R⁷, -CN, -CON(R⁷)(R¹³), -CF₃, or  

R³ is H, lower alkyl of 1 to 4 carbon atoms; 
Q is -O-, -(CR¹¹R¹⁴)n or a single bond; 

Q is -O-, -(CR¹¹R¹⁴)n, 
 

or a sinsle bond ; 
n is 1 to 5; 

A is -(CR¹¹R¹⁴)m-; 
m is 2 to 5, provided that n + m is not greater than 6; 

R¹¹ is H, lower alkyl of 1 to 4 carbon atoms (optionally 
substituted with -OR⁷, -CO₂R⁷, -CN, -N(R⁷) (R¹³), 

phenyl, substituted phenyl (substitution selected from 
mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 

nitro, O-alkyl of 1 to 3 carbon atoms, F, C1, 
or Br)), phenyl, substituted phenyl (substitution 

selected from mono-lower alkyl of 1 to 3 carbon atoms, 
trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 

F, Cl, or Br), pyridine, thiophene, furan, -OR⁷ 
-CO₂R⁷, -CN, -CON(R⁷)(R¹³), -CF₃, or 

 
R¹⁴ is H, lower alkyl of 1 to 4 carbon atoms (optionally 

substituted with -OR⁷, -CO₂R⁷, -CN, -N(R⁷) (R¹³), 
phenyl, substituted phenyl (substitution selected from 

mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 
nitro, O-alkyl of 1 to 3 carbon atoms, F, C1, 

 
or Br)), phenyl, substituted phenyl (substitution 

selected from mono-lower alkyl of 1 to 3 carbon atoms, 
trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 

F, Cl, or Br), pyridine, thiophene, furan, -OR⁷, 
-CO₂R⁷, -CN, -CON(R⁷)(R¹³), -CF₃, or 


The compound according to Claim 5 wherein 
X is a straight chain alkyl of 3 or 4 carbon atoms; 

R⁶ is 
A quinazolinone compound having the formula: 
 

wherein: 
X is straight or branched alkyl of 3 to 5 carbon atoms; 

R6B is: 
 

   and 
   R₁₈ is 

 
   or 

   -CN 
wherein 

R¹ is H, lower alkyl of 1 to 4 carbon atoms (optionally 
substituted with -OR⁷, -CO₂R⁷, -CN, -N(R⁷) (R¹³), 

 
phenyl, substituted phenyl (substitution selected from 

mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 
nitro, O-alkyl of 1 to 3 carbon atoms, F, Cl, 

or Br)), phenyl, substituted phenyl (substitution selected 
from mono-lower alkyl of 1 to 3 carbon atoms, 

trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 
F, Cl, or Br), pyridine, thiophene, furan, -OR⁷, 

-CO₂R⁷ -CN, -CON(R⁷)(R¹³), -CF₃, -SPh, -N(R⁷)(R¹³) or 
 

R² is H, lower alkyl of 1 to 4 carbon atoms (optionally 
substituted with -OR⁷, -CO₂R⁷, -CN, -N(R⁷) (R¹³), 

phenyl, substituted phenyl (substitution selected from 
mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 

nitro, O-alkyl of 1 to 3 carbon atoms, F, Cl, 
or Br)), phenyl, substituted phenyl (substitution selected 

from mono-lower alkyl of 1 to 3 carbon atoms, 
trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 

F, Cl, or Br), pyridine, thiophene, furan, -CO₂R⁷, -CN, 
-CON(R⁷)(R¹³), or 

 
R⁴ is H, -CO₂R⁷, -SO₂R¹², lower alkyl of 1 to 4 carbon 

atoms, benzyl, substituted benzyl (substitution selected 
from mono-lower alkyl of 1 to 3 carbon atoms, 

trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 
F, Cl, or Br) phenyl, substituted phenyl (substitution 

selected from mono-lower alkyl of 1 to 3 carbon atoms, 

trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 
F, Cl, or Br), -CON(R⁷)(R¹³), or  

R¹² is phenyl, substituted phenyl (substitution selected 
from mono-lower alkyl of 1 to 3 carbon atoms, 

trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 
F, Cl, or Br); 

R⁵ is H, lower alkyl of 1 to 4 carbon atoms; 
R⁷ is H, lower alkyl of 1 to 4 carbon atoms; 

R⁹ is H, lower alkyl of 1 to 4 carbon atoms, phenyl, 
substituted phenyl (substitution selected from 

mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 
nitro, O-alkyl of 1 to 3 carbon atoms, F, Cl, 

or Br); 
R¹³ is H, lower alkyl of 1 to 4 carbon atoms; 

Q¹ is -O-, -(CR¹¹R¹⁴)n, 
or a single bond ; 

n is 1 to 5; 
A is -(CR¹¹R¹⁴)m-; 

m is 2 to 5, provided that n + m is not greater than 6; 
R¹¹ is H, lower alkyl of 1 to 4 carbon atoms (optionally 

substituted with -OR⁷, -CO₂R⁷, -CN, -N(R7)(R¹³), 
phenyl, substituted phenyl (substitution selected from 

mono-lower alkyl of 1 to 3 carbon atoms, trifluoromethyl, 
nitro, O-alkyl of 1 to 3 carbon atoms, F, C1, 

or Br)), phenyl, substituted phenyl (substitution selected 
from mono-lower alkyl of 1 to 3 carbon atoms, 

trifluoromethyl, nitro, O-alkyl of 1 to 3 carbon atoms, 
F, Cl, or Br), pyridine, thiophene, furan, -OR⁷, 

-CO₂R⁷, -CN, -CON(R⁷)(R¹³), -CF₃, or  
R¹⁴ is H, lower alkyl of 1 to 4 carbon atoms 

(optionally substituted with -OR⁷, -CO₂R⁷, -CN, 
-N(R⁷)(R¹³), phenyl, substituted phenyl (substitution 

selected from mono-lower alkyl of 1 to 3 carbon atoms, 
trifluoro-methyl, nitro, O-alkyl of 1 to 3 carbon 

atoms, F, C1, or Br)), phenyl, substituted phenyl 
(substitution selected from mono-lower alkyl of 1 to 3 

carbon atoms, trifluoromethyl, nitro, O-alkyl of 1 to 3 
carbon atoms, F, C1, or Br), pyridine, thiophene, 

furan, -OR⁷, -CO₂R⁷, -CN, -CON(R⁷)(R¹³), -CF₃, or 

The compound according to Claim 1 
cis-(+/-)-2-butyl-6-(hexahydropyrrolo[1,2-b]
isoxazol-2-yl)-3-[[2''-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]
methyl]-4(3H)quinazolinone; 

cis-(+/-)-2-butyl-6-(hexahydro-2-methylpyrrolo[1,2-b]-isoxazol-2-yl)-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]
-4-yl]methyl]
-4(3H)-quinazolinone; 
(2S-cis)-2-butyl-6-(hexahydro-2-methylpyrrolo[1,2-b]
isoxazol-2-yl)-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone; 

(2R-cis)-2-butyl-6-(hexahydro-2-methylpyrrolo[1,2-b]isoxazol-2-yl)-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]
-4-yl]methyl]
-4(3H)-quinazolinone; 
(trans)-2-butyl-6-(hexahydro-2-methylpyrrolo[1,2-b]
isoxazol-2-yl)-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone;

 
(cis)-2-butyl-6-(hexahydro-2H-isoxazolo[2,3-a]
pyridin-2-yl)-3-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone; 

(cis)-2-butyl-6-(hexahydro-6,6-dimethylpyrrolo-[1,2b]isoxazol-2-yl)-3-[[2'-(1H-tetrazol-5-yl]
[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone; 

ethyl 2-[2-butyl-3,4-dihydro-4-oxo-3-[[2'-(1H-tetrazol5-yl)[1,1'-biphenyl]-4-yl]
methyl]-6-quinazolinyl]
hexahydro-pyrrolo[1,2-b]isoxazole-3-carboxylate; 

(cis)-2-butyl-6-(1,5,6,10b-tetrahydro-2H-isoxazolo-[3,-2-a]isoquinolin-2-yl)-3-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]
-4-yl]methyl]
-4(3H)-quinazolinone; 
(cis)-2-butyl-6-(1,5,6,10b-tetrahydro-2-methyl-2H-isoxazolo[3,2-a]
isoquinolin-2-yl)-3-[[2'-(1H-tetrazol-5-yl][1,1'-biphenyl]
-4-yl]methy]
-4(3H-quinazolinone; 
(trans)-2-butyl-6-(1,5,6,10b-tetrahydro-2-methyl-2H-isoxazolo[3,2-a]
isoquinolin-2-yl)-3-[[2'-(1H-tetrazol-5-yl][1,1'-biphenyl]
-4-yl]methyl]
-4(3H-quinazolinone); 
2-butyl-6-(hexahydro-3a-methyl]
-2H-isoxazolo[2,3-a]pyridin-3-yl)-3-[[2'-(1H-tetrazol-5-yl) 

[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone; 

(cis)-2-butyl-6-(hexahydro-2,6,6-trimethylpyrrolo[1,2-b]isoxazol-2-yl)-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]
-4-yl]methyl]
-4(3H)-quinazolinone; 
(cis)-2-butyl-6-(hexahydro-2-methyl-2H-isoxazolo-[2,3-a]
pyridin-2-yl)-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone; 

(trans)-2-butyl-6-(hexahydro-2-methyl-2H-isoxazolo[2,3-a]pyridin-2-yl)-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]
-4-yl]methyl]
-4(3H)-quinazolinone; 
(trans)-2-butyl-6-(hexahydro-2,6,6-trimethylpyrrolo[1,2-b]
isoxazol-2-yl)-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone; 

(cis)-2-butyl-6-(hexahydro-2-phenylpyrrolo[1,2-b]-isoxazol-2-yl)-3-[[2'-(1H-tetrazol-5-yl) 

[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone;

 
(cis)-2-butyl-6-(2-ethylhexahydropyrrolo[1,2-b]
isoxazol-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]
-4-yl]methyl]
-4(3H)-quinazolinone; 
(trans)-2-butyl-6-(2-ethylhexahydropyrrolo[1,2-b]
isoxazol-2-yl)-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone; 

(cis)-2-butyl-6-(hexahydro-2-methylpyrrolo[1,2-b] 

isoxazol-2-yl)-3-[[2'-(1H-tetrazol-5-yl) [1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone, 

sodium salt; 
(2S-cis)-2-butyl-6-(hexahydro-2-methylpyrrolo[1,2-b]
 
isoxazol-2-yl)-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]
-4-yl]methyl]
-4(3H)-quinazolinone, 
sodium salt; 

(2R-cis)-2-butyl-6-(hexahydro-2-methylpyrrolo[1,2-b] 

isoxazol-2-yl)-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone,sodium 

salt; 
or 

(trans)-2-butyl-6-(hexahydro-2-methylpyrrolo[1,2-b] 

isoxazol-2-yl)-3-[[2'-(1H-tetrazol-5-yl) [1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone,sodium 

salt; 
The compound according to Claim 5 
cis-(+/-)-2-butyl-6-(hexahydropyrrolo[1,2-b]
isoxazol-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl] 

[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone; 

cis-(+/-)-2-butyl-6-(hexahydro-2-methylpyrrolo[1,2-b]-isoxazol-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl]
[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone; 

(2S-cis)-2-butyl-6-(hexahydro-2-methylpyrrolo[1,2-b]-isoxazol-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl]
[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone; 

(2R-cis)-2-butyl-6-(hexahydro-2-methylpyrrolo[1,2-b]-isoxazol-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl]
[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone; 

trans-2-butyl-6-(hexahydro-2-methylpyrrolo[1,2-b] 

isoxazol-2-yl)3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]
-4-yl]-methyl]
-4-(3H)-quinazolinone;
 

(cis)-2-butyl-6-(hexahydro-2H-isoxazolo[2,3-a]-pyridin-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl]
[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone; 

trans-2-butyl-6-(hexahydro-2H-isoxazolo[2,3-a]-pyridin-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl]
-[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone; 

cis-2-butyl-6-(hexahydro-6,6-dimethylpyrrolo[1,2-b]isoxazol-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl]
 
[1,1'-biphenyl]
-4-yl]methyl]
-4(3H)-quinazolinone; 
ethyl 

2-[2-butyl-3,4-dihydro-4-oxo-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]
-4-yl]-methyl]
-6-quinazolinyl]hexahydro-pyrrolo[1,2-b]
isoxazole-3-carboxylate; 
cis-2-butyl-6-(1,5,6,10b-tetrahydro-2H-isoxazolo-[3,2-a]
isoquinolin-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]
-4-yl]methyl]
-4(3H)-quinazolinone; 
cis-2-butyl-6-(1,5,6,10b-tetrahydro-2-methyl-2H-isoxazolo[3,2-a]
isoquinolin-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]
-4-yl]-methyl]
-4(3H-quinazolinone); 
trans-2-butyl-6-(1,5,6,10b-tetrahydro-2-methyl-2H-isoxazolo[3,2-a]
isoquinolin-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl] 

[1,1'-biphenyl]-4-yl]
methyl]-4(3H-quinazolinone; 

-cis-2-butyl-6-(hexahydro-3a-methyl-2H-isoxazolo[2, 
3-a]
pyridin-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-s-yl][1,1'-biphenyl]
-4-yl]methyl-4-(3H)-quinazolinone; 

cis(+/-)-2-butyl-6-(hexahydro-2,6,6-trimethylpyrrolo-[1,2-b]isoxazol-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl]
[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone; 

trans(+/-)-2-butyl-6-(hexahydro-2,6,6-trimethylpyrrolo-[1,2-b]isoxazol-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl]
[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone;

 
cis-2-butyl-6-(hexahydro-2-methyl-2H-isoxazolo-[2,3-a]
pyridin-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]
-4-yl]methyl]
-4(3H)-quinazolinone; 
trans-2-butyl-6-(hexahydro-2-methyl-2H-
isoxazolo-[2,3-a]pyridin-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl]
[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone; 

cis-2-butyl-6-(hexahydro-2-phenylpyrrolo[1,2-b]-isoxazol-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl]
[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone; 

cis-2-butyl-6-(2-ethylhexahydropyrrolo[1,2-b]isoxazol-2-yl)-3-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl]
[1,1'-biphenyl]-4-yl]
methyl]-4(3H)-quinazolinone; 

or 
trans-2-butyl-6-(2-ethylhexahydropyrrolo[1,2-b]
 
isoxazol-2-yl)-3-[[2'-[1-triphenylmethyl)-1H-tetrazol-5-yl]
[1,1'-biphenyl]-4-yl]
-methyl]-4(3H)-quinazolinone; 
A pharmaceutical composition useful for 
treating angiotensin induced hypertension or congestive 

heart failure in a mammal comprising a suitable pharmaceutical 
carrier and an effective amount of a compound 

of Claim 1. 
A method of treating angiotensin induced 
hypertension in a mammal comprising administering a 

compound of Claim 1 to said mammal an amount effective 
to lower angiotensin induced hypertension. 
A process for preparing a compound of 
Claim 1 which comprises reacting a compound of the 

formula:  
where R¹, R², R¹⁰ and X are defined in Claim 1 and 

R¹⁸ is 
 

with a compound of the formula: 
 

wherein R³, R⁸, Q and A are defined in Claim 1 to obtain 
an intermediate of the formula:  

wherein R6A is: 
 

and obtaining a free tetrazole compound according to 
claim by either removing the triphenylmethyl protecting 

group to from the R¹⁸ protected tetrazole or reacting 
the the R¹⁸ cyano group with sodium azide. 
</CLAIMS>
</TEXT>
</DOC>
